BEIJING, July 18, 2025 -- The business innovation case of Waterdrop Inc. (NYSE:WDH), Waterdrop: AI-Powered Insurance and Healthcare, was recently included in Harvard Business School (HBS)'s Case Collection, receiving recognition from this world-renowned academic institution. Developed by Professor Li Qi from the School of Management and Economics at The Chinese University of Hong Kong (Shenzhen), the case examines how Waterdrop has applied advanced AI technologies to drive systematic innovation and strategic transformation amid profound changes in the insurance and healthcare sectors. By fost
SHANGHAI, July 18, 2025 -- Jointly organized by the China Chamber of Commerce for Import & Export of Medicines & Health Products and Sinoexpo Informa Markets, the "Healthplex Expo 2025, Natural & Nutraceutical Products China 2025" (HNC 2025) was successfully held from June 24 to 26 at the National Exhibition and Convention Center (Shanghai). The HNC 2025 once again achieved a historic breakthrough in scale, winning high praise from all participants. Held concurrently with Hi & Fi Asia-China, ProPak China & FoodPack China, and Starch Expo, the HNC built a business
XIAMEN, China, July 18, 2025 -- Brain-Computer Interface (BCI) technology is redefining human-machine interaction by establishing direct communication between the brain and external devices. This transformative innovation is driving profound societal impact across industries: revolutionizing neurological disease treatment (e.g., epilepsy, Parkinson's, and depression), enhancing educational outcomes through improved focus, and enabling seamless industrial human-robot collaboration. With aging populations and rising neurological disorders worldwide, BCI's healthcare applications are experiencin
GOTHENBURG, Sweden, July 18, 2025 -- "The positive start to 2025 continued in the second quarter, with stable organic growth in order intake and sales, and our margins strengthened despite strong headwinds from tariffs and negative currency effects," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased organically by 4.1% while order intake rose by 4.4% organically. Business area Acute Care Therapies continues to be successful in handling the increased demand for ventilators, and the order intake in ECLS consumables remains high. The
LONDON, July 18, 2025 -- On July 22, the World Federation of Neurology (WFN) will celebrate its 12th annual World Brain Day, with the theme "Brain Health for All Ages." The official event of World Brain Day is a webinar, open to the public, taking place at 1:00 p.m. BST. World Brain Day is an annual event uniting the global community to protect and promote healthy brains. The webinar serves as a global call to action for both individuals, healthcare providers, non-governmental organizations, community leaders, policy-makers, and institutions to share meaningf
[ 메디채널 김갑성 기자 ] New Funding Fuels Growth in Medical Insurance and Innovation in Preventive Healthcare HONG KONG, July 18, 2025 -- Bowtie, Hong Kong's first virtual insurer[1], is proud to announce securing up to US$70 million in its Series C funding round. Led by Sun Life Hong Kong Limited ("Sun Life"), this marks the largest funding round for digital health insurers in Asia with a direct-to-consumer model. Bowtie continues to lead in Hong Kong's digital insurance market, ranking first in the direct channel[2], and securing the 9th position across all dist
SEOUL, South Korea, July 18, 2025 -- DeepQure announced today that South Korea's Ministry of Food and Drug Safety (MFDS) has approved a clinical trial of HyperQure™ RDM System, the company's novel laparoscopic renal denervation (RDN) system, for the treatment of atrial fibrillation (AF). The trial is designed to evaluate the safety and efficacy of laparoscopic RDN in patients with recurrent AF following pulmonary vein isolation (PVI) and resistant hypertension. It will be conducted as a multicenter, prospective, single-arm, open-label exploratory study. HyperQure™ is a next-gene
[ 메디채널 김갑성 기자 ] KAWASAKI, Japan and NEW TAIPEI CITY, July 18, 2025 -- Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a collaborative agreement to develop "aiGait" powered by Uvance, a solution that leverages Fujitsu's advanced skeleton recognition AI technology to detect gait pattern abnormalities, and provide gait quantization to healthcare professionals to support the early diagnosis of dementia and Parkinson's disease. The technology is part of "Fujitsu Kozuchi for Vision" from the Fujitsu Uva
NEW YORK, July 17, 2025 -- Lifezoom, a pioneer of red light therapy in the USA, is excited to expand with the new industry-leading Veyra Series, red light therapy panels that mix creativity, adaptability, and health-focused design. Now, with two launch products, Veyra C and Veyra S, this versatile red light technology, built on a flexible silicone base material, is available throughout the U.S and Europe at the starting price of $249. After years of research and development, the Lifezoom engineering team from Iowa's hardworking community has brought to market a product that not
SYDNEY, July 17, 2025 -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Co-PSMA (NCT06907641)[1] Investigator-Initiated Trial (IIT) led by Prof Louise Emmett at St Vincent's Hospital Sydney has now completed study enrolment, with all participants having been imaged. The study is evaluating the performance of Clarity's diagnostic product, 64Cu-SAR-b